Comparison of Change in Lipoprotein(a) Mass and Molar Concentrations by Alirocumab and Risk of Subsequent Cardiovascular Events in ODYSSEY OUTCOMES. Academic Article

Overview

authors

Szarek, Michael

Reijnders, Esther

Steg, Ph Gabriel

Jukema, J Wouter

Schwertfeger, Markus

Bhatt, Deepak L

Bittner, Vera A

Garon, Genevieve

Goodman, Shaun G

Harrington, Robert
White, Harvey D
Zeiher, Andreas M
Cobbaert, Christa
Schwartz, Gregory G

publication date

March 19, 2024

published in

European journal of preventive cardiology Journal

Research

keywords

Antibodies, Monoclonal, Humanized
Cardiovascular Diseases
Lipoprotein(a)

Identity

Digital Object Identifier (DOI)

10.1093/eurjpc/zwae110

PubMed ID

38501249